IP Library Granted Patent US 10,772,671
Granted Patent B2
US 10,772,671 · App. 16/393,400 · Granted Sep 15, 2020

System and method for treating cancer through DNA damage with cold atmospheric plasma with self-organized patterns

Inventors: Zhitong Chen (Ashburn, VA); Jerome Canady (Lakeland, FL); Michael Keidar (Baltimore, MD)
Assignee: US Patent Innovations, LLC
A61B18/042A61B2017/00526A61B2018/00333
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,772,671
App. No.
16/393,400
Granted
Sep 15, 2020
Kind
B2
Abstract

Cold atmospheric plasma is an emerging technology in the treatment of cancer. Meanwhile, different types of self-organized pattern (SOP) phenomenon have been reported in a wide of range of plasmas. In this paper, we describe the application of SOP plasma to two breast cancer cells MDA-MB-231 and MCF-7. Specifically, the effect of SOP plasma on reactive oxygen and nitrogen species (RONS) were investigated. SOP plasma-generated RONS displayed significantly decreased cancer cell viability in both breast cancer cell lines; significantly inhibiting cell proliferation via while inducing apoptosis. SOP plasma induced DNA damage, activating the ATM/ATR kinase signaling cascade. ATR phosphorylates the checkpoint effector kinase Chk-1 activating γ-H2AX resulting in cell cycle arrest and ATM induced apoptosis. Taken together, we have provided new insight into the action mechanism of action by which elevated SOP plasma first induces ROS generation and then results into a DNA damage response, ultimately inducing apoptosis.

Claims (18)

1. A method for treatment of cancer cells comprising:

positioning an electrode at a distance of less than 10 mm from a surface of a media in a container;

flowing an inert gas from a source of inert gas past said electrode and onto said surface of said media in said container;

applying electrical energy to said electrode with an electrosurgical generator while said inert gas is flowing past said electrode for a fixed period of time to generate a plasma self-organized pattern at a surface of said media to induce reactive oxygen and nitrogen species generation in said media; and

exposing human cancer cells to said plasma activated media to cause DNA damage in said human cancer cells.

2. The method for treatment of cancer cells according to claim 1 wherein said step of treating human cancer cells with said plasma activated media comprises injecting said plasma activated media into an area of a human body containing said human cancer cells.

3. The method for treatment of cancer cells according to claim 1 wherein said human cancer cells comprise human breast cancer cells.

4. The method for treatment of cancer cells according to claim 1 wherein said fixed distance is 4-6 mm.

5. The method for treatment of cancer cells according to claim 1 wherein said fixed time is 40 seconds.

6. A method for treating cancer cells according to claim 1 , wherein said step of applying electrical energy comprises applying electrical energy having a wavelength of 200-280 nm.

7. A method for treating cancer cells according to claim 1 , wherein said media comprises saline.

8. The method for manufacturing plasma-activated media for treatment of cancer cells according to claim 1 wherein said self-organized pattern comprises a double ring.

9. A method for manufacturing plasma-activated media for treatment of cancer cells comprising:

generating with an atmospheric discharge between an electrode and a surface of a liquid media to generate a plasma self-organized pattern at said surface of media, wherein the electrode is at a distance from the surface of the media and a plasma is formed in a gap between said electrode and said surface of said media; and

maintaining said atmospheric discharge for a period of time greater than 10 seconds to generate reactive oxygen and nitrogen species.

10. The method for manufacturing plasma-activated media for treatment of cancer cells according to claim 9 wherein said distance between the electrode and the surface of the media is 4-6 mm.

11. The method for manufacturing plasma-activated media for treatment of cancer cells according to claim 9 wherein said self-organized pattern comprises a double ring.

12. The method for manufacturing plasma-activated media for treatment of cancer cells according to claim 9 wherein said media comprises saline solution.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2019
From: CHEN, ZHITONG; CANADY, JEROME, DR.; KEIDAR, MICHAEL
To: US PATENT INNOVATIONS, LLC
Reel/Frame 050182/0908 →
Continuity (4)
Continuation In Part 16298484 · Mar 11, 2019
Provisional Application 62662466 · Apr 25, 2018
Provisional Application 62640886 · Mar 9, 2018
Related Publication 20190274747A1 · Sep 12, 2019